Read more from the original source: Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines
Read more from the original source: Parexel Joins Decentralized Trials & Research Alliance (DTRA) to Enhance Patient Access, Increase Diversity and Accelerate Trial Timelines
Read the original here: FDA approves Roche’s OCREVUS® (ocrelizumab) shorter 2-hour infusion for relapsing and primary progressive multiple sclerosis
Read the original here: AgraFlora Organics Receives Standard Processing Licence for its Winnipeg Edibles Manufacturing Facility
See more here: Addex Announces Filing of Registration Statement for Proposed Public Offering of Securities
See the original post: Opiant Pharmaceuticals Announces Additional $3.5 million Funding Under BARDA Contract for OPNT003 Nasal Nalmefene Development Program
Read the original here: Ascendis Pharma A/S Announces Planned Board Transition
Read the original: ERYTECH Completes Enrollment in TRYbeCA-1 Phase 3 Trial in Second-Line Pancreatic Cancer
View original post here: MediWound Continues Global Expansion with Distribution Agreement for NexoBrid in United Arab Emirates with Ghassan Aboud Group
Continue reading here: Mesoblast Provides Topline Results From Phase 3 Trial of Rexlemestrocel-L for Advanced Chronic Heart Failure
Originally posted here: Mesoblast Corporate Update
Recent Comments